• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哥伦比亚卡塔赫纳一家风湿病护理中心类风湿关节炎患者中白细胞介素6与肝脂肪变性和肝纤维化的关系

Relationship of Interleukin 6 with Hepatic Steatosis and Liver Fibrosis in Rheumatoid Arthritis at a Rheumatology Care Center in Cartagena, Colombia.

作者信息

Pérez-Mingan Gloria Caterine, Sierra-Merlano Rita Magola, Yepes Ismael, Vergara María Judith Palomino, Ortiz Miguel, Peña Breiner, Cano-Pérez Eder, Gómez-Camargo Doris

机构信息

Departamento de Medicina Interna, Facultad de Medicina, Universidad de Cartagena, Cartagena 130001, Colombia.

Programa de Medicina, Facultad de Medicina, Universidad de Cartagena, Cartagena 130001, Colombia.

出版信息

Genes (Basel). 2024 Dec 21;15(12):1639. doi: 10.3390/genes15121639.

DOI:10.3390/genes15121639
PMID:39766906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11675702/
Abstract

BACKGROUND/OBJECTIVES: This study aimed to investigate the association of IL-6 with steatotic liver disease (SLD) and liver fibrosis (LF) in rheumatoid arthritis (RA) patients at a rheumatology center in Cartagena de Indias, Colombia.

METHODS

This was a cross-sectional study that included RA and non-RA cases. The level of cellular expression of interleukin 6 (IL-6) was evaluated by flow cytometry in peripheral blood leukocytes, and the presence of SLD and LF was detected by elastosonography. The main outcome was to establish the association between the levels of cellular expression of IL-6 and the development of SLD and LF.

RESULTS

This study included 47 cases of RA and 34 cases on-RA, with a mean age of 54 and 55 years, respectively. The frequency of SLD was 55.3% in RA and 38.2% in non-RA. The frequency of LF was 12.8% in RA and 14.7% in non-RA, with no statistical difference. The levels of cellular expression of IL-6 were significantly higher in RA compared to non-RA. Cellular expression of IL-6 was associated with the presence of SLD (54% vs. 30.3%; = 0.002). This association was not maintained in RA cases (49.5% vs. 47.6%; = 0.571). No association was found between cellular expression of IL-6 and LF in the total population (43.8% vs. 42.7%; = 0.813) nor in RA cases (59.41% vs. 48.3%; = 0.526).

CONCLUSIONS

IL-6 levels were related to SLD in the evaluated sample, and RA was not a risk factor for SLD or LF. The prognostic role of IL-6 for SLD in patients with RA requires further studies.

摘要

背景/目的:本研究旨在调查在哥伦比亚印度卡塔赫纳的一个风湿病中心,类风湿关节炎(RA)患者中白细胞介素-6(IL-6)与脂肪性肝病(SLD)及肝纤维化(LF)之间的关联。

方法

这是一项横断面研究,纳入了RA病例和非RA病例。通过流式细胞术评估外周血白细胞中白细胞介素6(IL-6)的细胞表达水平,并用弹性超声检查检测SLD和LF的存在情况。主要结果是确定IL-6的细胞表达水平与SLD和LF发生之间的关联。

结果

本研究纳入了47例RA患者和34例非RA患者,平均年龄分别为54岁和55岁。RA患者中SLD的发生率为55.3%,非RA患者中为38.2%。RA患者中LF的发生率为12.8%,非RA患者中为14.7%,无统计学差异。与非RA患者相比,RA患者中IL-6的细胞表达水平显著更高。IL-6的细胞表达与SLD的存在相关(54%对30.3%;P = 0.002)。在RA病例中这种关联未持续存在(49.5%对47.6%;P = 0.571)。在总体人群中未发现IL-6的细胞表达与LF之间存在关联(43.8%对42.7%;P = 0.813),在RA病例中也未发现(59.41%对48.3%;P = 0.526)。

结论

在所评估的样本中,IL-6水平与SLD相关,且RA不是SLD或LF的危险因素。IL-6对RA患者SLD的预后作用需要进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8c/11675702/407e453b6280/genes-15-01639-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8c/11675702/407e453b6280/genes-15-01639-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1f8c/11675702/407e453b6280/genes-15-01639-g001.jpg

相似文献

1
Relationship of Interleukin 6 with Hepatic Steatosis and Liver Fibrosis in Rheumatoid Arthritis at a Rheumatology Care Center in Cartagena, Colombia.哥伦比亚卡塔赫纳一家风湿病护理中心类风湿关节炎患者中白细胞介素6与肝脂肪变性和肝纤维化的关系
Genes (Basel). 2024 Dec 21;15(12):1639. doi: 10.3390/genes15121639.
2
Prevalence of Steatotic Liver Disease Among US Adults with Rheumatoid Arthritis.美国类风湿关节炎成年患者中脂肪性肝病的流行率。
Dig Dis Sci. 2024 Mar;69(3):989-1003. doi: 10.1007/s10620-023-08225-4. Epub 2024 Jan 6.
3
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk factors in rheumatoid arthritis.类风湿关节炎中的代谢功能障碍相关脂肪性肝病与心血管危险因素
Clin Rheumatol. 2025 Apr;44(4):1485-1492. doi: 10.1007/s10067-025-07364-5. Epub 2025 Feb 17.
4
Increased risk of vascular complications in patients with type 2 diabetes and fatty liver disease.2 型糖尿病合并脂肪肝患者血管并发症风险增加。
BMC Endocr Disord. 2024 Nov 5;24(1):235. doi: 10.1186/s12902-024-01766-3.
5
[Diagnostic Value of Interleukin 6, Interleukin 12P70, Serum Amyloid A, and Procalcitonin for Rheumatoid Arthritis and Their Relationship With the Disease Activity].[白细胞介素6、白细胞介素12P70、血清淀粉样蛋白A及降钙素原对类风湿关节炎的诊断价值及其与疾病活动度的关系]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Jul 20;55(4):995-1000. doi: 10.12182/20240760107.
6
Thy-1 restricts steatosis and liver fibrosis in steatotic liver disease.Thy-1 可限制脂肪变性肝病中的脂肪变性和肝纤维化。
Liver Int. 2024 Aug;44(8):2075-2090. doi: 10.1111/liv.15956. Epub 2024 May 4.
7
[Detection of peripheral follicular helper T cells in rheumatoid arthritis].[类风湿关节炎中外周滤泡辅助性T细胞的检测]
Beijing Da Xue Xue Bao Yi Xue Ban. 2016 Dec 18;48(6):951-957.
8
High Interleukin-37 (IL-37) Expression and Increased Mucin-Domain Containing-3 (TIM-3) on Peripheral T Cells in Patients with Rheumatoid Arthritis.类风湿关节炎患者外周血 T 细胞中白细胞介素 37(IL-37)表达升高和黏蛋白结构域包含蛋白 3(TIM-3)增加。
Med Sci Monit. 2018 Aug 14;24:5660-5667. doi: 10.12659/MSM.909254.
9
Liver and atherosclerotic risks of patients with cryptogenic steatotic liver disease.隐匿性脂肪性肝病患者的肝脏与动脉粥样硬化风险。
Hepatol Int. 2024 Jun;18(3):943-951. doi: 10.1007/s12072-023-10624-8. Epub 2024 Jan 16.
10
Prevalence, distribution, and hepatic fibrosis burden of the different subtypes of steatotic liver disease in primary care settings.基层医疗环境中不同类型脂肪性肝病的流行情况、分布情况以及肝脏纤维化负担。
Hepatology. 2024 Jun 1;79(6):1393-1400. doi: 10.1097/HEP.0000000000000664. Epub 2023 Nov 1.

本文引用的文献

1
Association between body roundness index and non-alcoholic fatty liver disease detected by Fibroscan in America.在美国,通过 Fibroscan 检测到的体圆度指数与非酒精性脂肪肝的相关性。
J Clin Lab Anal. 2023 Oct;37(19-20):e24973. doi: 10.1002/jcla.24973. Epub 2023 Oct 18.
2
IL-6 Trans-Signaling Is Increased in Diabetes, Impacted by Glucolipotoxicity, and Associated With Liver Stiffness and Fibrosis in Fatty Liver Disease.IL-6 反式信号在糖尿病中增加,受糖脂毒性影响,并与脂肪肝中的肝硬度和纤维化相关。
Diabetes. 2023 Dec 1;72(12):1820-1834. doi: 10.2337/db23-0171.
3
Changing epidemiology, global trends and implications for outcomes of NAFLD.
非酒精性脂肪性肝病的流行病学变化、全球趋势及其对结局的影响。
J Hepatol. 2023 Sep;79(3):842-852. doi: 10.1016/j.jhep.2023.04.036. Epub 2023 May 9.
4
Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-analysis.类风湿关节炎患者中非酒精性脂肪性肝病的患病率:系统评价和荟萃分析。
Clin Gastroenterol Hepatol. 2023 Oct;21(11):2789-2796. doi: 10.1016/j.cgh.2023.02.021. Epub 2023 Mar 5.
5
IL-6/STAT3 axis dictates the PNPLA3-mediated susceptibility to non-alcoholic fatty liver disease.IL-6/STAT3 轴决定了 PNPLA3 介导的非酒精性脂肪性肝病易感性。
J Hepatol. 2023 Jan;78(1):45-56. doi: 10.1016/j.jhep.2022.08.022. Epub 2022 Aug 30.
6
After the Genome-A Brief History of Proteomics.《基因组之后——蛋白质组学简史》
JAMA. 2022 Sep 27;328(12):1168-1169. doi: 10.1001/jama.2022.7448.
7
Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk in Patients With Rheumatoid Arthritis: A Cross-Sectional Study of Chinese Cohort.类风湿关节炎患者代谢功能障碍相关脂肪性肝病与心血管风险的关联:一项中国队列的横断面研究
Front Cardiovasc Med. 2022 May 13;9:884636. doi: 10.3389/fcvm.2022.884636. eCollection 2022.
8
Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease.炎症细胞因子与非酒精性脂肪性肝病的关系。
Front Immunol. 2022 May 6;13:880298. doi: 10.3389/fimmu.2022.880298. eCollection 2022.
9
The burden of the most common rheumatic disease in Colombia.哥伦比亚最常见的风湿性疾病负担。
BMC Rheumatol. 2022 Jan 20;6(1):7. doi: 10.1186/s41927-021-00234-y.
10
Cellular and molecular diversity in Rheumatoid Arthritis.类风湿关节炎中的细胞和分子多样性
Semin Immunol. 2021 Dec;58:101519. doi: 10.1016/j.smim.2021.101519. Epub 2022 Jan 13.